Medication adherence in patients with asthma using once-daily versus twice-daily ICS/LABAs-Reference-Cited by-同舟云学术

Medication adherence in patients with asthma using once-daily versus twice-daily ICS/LABAs

Published:2019-10-14 Issue:1 Volume:58 Page:102-111
ISSN:0277-0903
Container-title:Journal of Asthma
language:en
Short-container-title:Journal of Asthma

Author:

Averell Carlyne M.¹,Stanford Richard H.¹,Laliberté François²,Wu Jennifer W.²,Germain Guillaume²,Duh Mei Sheng³

Affiliation:

1. GSK, Research Triangle Park, NC, USA

2. Groupe d’analyse, Ltée, Montreal, QC, Canada

3. Analysis Group, Inc, Boston, MA, USA

Funder

GlaxoSmithKline

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/02770903.2019.1663429

Reference33 articles.

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention 2018 [updated Mar 2018]. Available from: http://ginasthma.org/2018-gina-report-global-strategy-for-asthma-management-and-prevention/.

2. National Heart Lung and Blood Institute. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. 2007.

3. Add-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhaler

4. US Food and Drug Administration. New Drug Application (NDA): 204275 (Breo Ellipta) 2013 [cited 2018 Dec 19]. Available from: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204275.

5. US Food and Drug Administration. New Drug Application (NDA): 021929 (Symbicort) 2006 [cited 2018 Dec 19]. Available from: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021929.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asthma prescribing trends, inhaler adherence and outcomes: a Real-World Data analysis of a multi-ethnic Asian Asthma population;2024-07-11

2. Smaller Differences in the Comparative Effectiveness of Biologics in Reducing Asthma-Related Hospitalizations Compared With Overall Exacerbations;The Journal of Allergy and Clinical Immunology: In Practice;2024-06

3. Factors Affecting Adherence in Allergic Disorders and Strategies for Improvement;The Journal of Allergy and Clinical Immunology: In Practice;2024-06

4. Efficacy and safety of Once-Daily Vilanterol/Fluticasone furoate MDI in persistent asthma: Phase 3 OD-INHALE Study;Journal of Asthma;2024-04-04

5. The Saudi initiative for asthma – 2024 update: Guidelines for the diagnosis and management of asthma in adults and children;Annals of Thoracic Medicine;2023-12-15